Evidence map›Paper›PMID 24742105›Full record

ArticleBMC pediatrics2014

Successful control of a neonatal outbreak caused mainly by ST20 multidrug-resistant SHV-5-producing Klebsiella pneumoniae, Greece.

Angeliki Mavroidi, Apostolos Liakopoulos, Antonios Gounaris, Maria Goudesidou, Katerina Gaitana, Vivi Miriagou, Efthymia Petinaki

Open access · goldAbstract read
In one paragraph

Article in BMC pediatrics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Carriage of hypervirulent and ESBL-producingApplied and environmental microbiology · 2026
    Article
  4. Article
  5. Antibiotic resistance and novel Sequence Types ofCurrent research in microbial sciences · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Antimicrobial Resistance Genes in ESBL-ProducingAntibiotics (Basel, Switzerland) · 2021
    Article
  14. Article
  15. FecalFrontiers in microbiology · 2020
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Characteristics of carbapenemase-producingExperimental and therapeutic medicine · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Angeliki Mavroidi
Apostolos Liakopoulos
Antonios Gounaris
Maria Goudesidou
Katerina Gaitana
Vivi Miriagou
Efthymia PetinakiDepartment of Microbiology, University Hospital of Larissa, Larissa, Greece. petinaki@med.uth.gr.
University Hospital of Larissa · GRPasteur Hellenic Institute · GRUniversity of Thessaly · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundExtended spectrum beta-lactamase-producing Klebsiella pneumoniae (ESBL-Kp) infection can cause significant morbidity and mortality in neonates. We investigated a nosocomial ESBL-Kp outbreak in a neonatal intensive care unit (NICU) of the University Hospital of Larissa (UHL), Central Greece.

methodsA total of sixty-four ESBL-Kp were studied; twenty six isolates were recovered from the NICU and were compared with thirty-eight randomly selected isolates from different wards of the hospital during the period March- December 2012. All isolates were characterized by antimicrobial susceptibility testing, ESBL-production by double-disk synergy test, molecular typing using BOX-PCR, whereas selected isolates were further characterized by beta lactamase and virulence gene content, multilocus sequence typing and phylogenetic analysis. All neonates affected by ESBL-Kp were put under strict contact isolation, along with appropriate infection control measures.

resultsThe outbreak strain of ST20 multidrug-resistant SHV-5-producing K. pneumoniae was identified in all infected (n = 13) and three colonized neonates. A novel ST (ST1114) was also identified among SHV-5 producers (n = 10) recovered from nine colonized infants, but it was not related with ST20. Both STs were identified only in the NICU and not in other wards of the hospital. No ESBL-Kp were isolated from the hands of the nursing staff and the environment. Although we were not able to identify the source of the outbreak, no ESBL-Kp were isolated in the NICU after this period and we assumed that the outbreak was successfully controlled. All neonates received parenteral nutrition and most of them were delivered by caesarean section and showed low gestational age (<32 weeks) and low birth weights (<1500 g).

conclusionAccording to our knowledge, this is the first description of an outbreak of multidrug-resistant SHV-5 producing K. pneumoniae assigned to ST20.

Indexed as

Intensive Care Units, Neonatalbeta-LactamasesCatheterization, Central VenousCesarean SectionChest TubesCross InfectionDisease OutbreaksDNA, BacterialDrug Resistance, Multiple, BacterialFemaleGestational AgeGreeceHumansInfant, Low Birth WeightInfant, NewbornInfection Controlbeta-Lactamasesbeta-lactamase SHV-5DNA, Bacterial

Identifiers

PMID24742105
PMCPMC4011775
OpenAlexW2115624895

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.